Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10829529 Compositions and methods for delivering CFTR polypeptides

Patent 10829529 was granted and assigned to Krystal Biotech on November, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Krystal Biotech

Current Assignee

Krystal Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

108295290

Date of Patent

November 10, 2020

Patent Application Number

167845990

Date Filed

February 7, 2020

Patent Citations

‌

US Patent 10441614 Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

‌

US Patent 10155016 Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

‌

US Patent 10525090 Compositions and methods for the treatment of autosomal recessive congenital ichthyosis

Patent Citations Received

‌

US Patent 11918660 Viral vectors for cancer therapy

‌

US Patent 11779660 Viral vectors for cancer therapy

Patent Primary Examiner

‌

Kevin K Hill

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10829529 Compositions and methods for delivering CFTR polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API